Beta Drugs IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 1,083,200 (47%) | — | ₹921 Cr |
| Retail | — | 1,083,200 (47%) | — | ₹921 Cr |
| Market Maker | — | 129,600 (6%) | — | ₹11 Cr |
| Σ Total | — | 2,296,000 (100%) | — | ₹19,516 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹136,000 |
| Retail (Max) | 13 | 20,800 | ₹1,768,000 |
| S-HNI (Min) | 14 | 22,400 | ₹1,904,000 |
| B-HNI (Min) | 67 | 107,200 | ₹9,112,000 |
Financial Statements Amount in Lacs
| Metric | 31.03.2017 | 31.03.2016 | 31.03.2015 |
|---|---|---|---|
| Revenue | 4,168 | 2,639 | 26 |
| Profit After Tax | 427 | 77 | 11 |
| Net Worth | 738 | 220 | 107 |
| Total Assets | 2,454 | 1,520 | 801 |
| Reserves & Surplus | 637 | 119 | 6 |
| Total Borrowing | 752 | 752 | 752 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Market Maker Shares Offered – 1,29,600 (5.64%)
- NII (HNI) Shares Offered – 10,83,200 (47.18%)
- Retail Shares Offered – 10,83,200 (47.18%)
- Total Shares Offered – 22,96,000 (100.00%)
Company Overview
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.
Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.
Company Strengths:
1. Focus on oncology segment. Manufacture over 50 products in this segment.
2. 18 product registrations in various countries. Company is in-process of making additional 12 applications for product registration in various countries.